Evidence map›Paper›PMID 33243791›Full record

ArticleBMJ open2020

Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial.

Daisuke Fujisawa, Shigeki Umemura, Ayumi Okizaki, Eriko Satomi, Takuhiro Yamaguchi, Tempei Miyaji, Tomoe Mashiko, Naoko Kobayashi, Hiroya Kinoshita, Masanori Mori and 5 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Appropriate referral timing to specialized palliative care service: survey of bereaved families of cancer patients who died in palliative care units.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daisuke FujisawaDepartment of Neuropsychiatry, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.ORCID 0000-0003-1913-6955
Shigeki UmemuraDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Ayumi OkizakiDepartment of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.ORCID 0000-0001-6685-965X
Eriko SatomiDepartment of Palliative Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Takuhiro YamaguchiDivision of Biostatistics, Tohoku University School of Medicine, Sendai, Miyagi, Japan.
Tempei MiyajiInnovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.ORCID 0000-0001-8370-1352
Tomoe MashikoInnovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Naoko KobayashiDepartment of Nursing, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Hiroya KinoshitaDepartment of Palliative Care, Tokatsu Hospital, Nagareyama, Chiba, Japan.
Masanori MoriPalliative and Supportive Care, Seirei Mikatahara Hospital, Hamamatsu, Shizuoka, Japan.
Tatsuya MoritaPalliative and Supportive Care, Seirei Mikatahara Hospital, Hamamatsu, Shizuoka, Japan.
Yosuke UchitomiInnovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Koichi GotoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Yuichiro OheDepartment of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
Yoshihisa MatsumotoDepartment of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, Chiba, Japan yosmatsu@east.ncc.go.jp.ORCID 0000-0003-3112-4818

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt has been suggested that palliative care integrated into standard cancer treatment from the early phase of the disease can improve the quality of life of patients with cancer. In this paper, we present the protocol for a multicentre randomised controlled trial to examine the effectiveness of a nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer. METHODS AND ANALYSIS: A total of 206 patients will be randomised (1:1) to the intervention group or the control group (usual care). The intervention, triggered with a brief self-administered screening tool, comprises comprehensive need assessments, counselling and service coordination by advanced-level nurses. The primary outcome is the Trial Outcome Index of the Functional Assessment of Cancer Therapy (FACT) at 12 weeks. The secondary outcomes include participants' quality of life (FACT-Lung), depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder-7), illness perception (Prognosis and Treatment Perceptions Questionnaire), medical service use and survival. A mixed-method approach is expected to provide an insight about how this intervention works. ETHICS AND DISSEMINATION: This study has been approved by the Institutional Review Board of the National Cancer Center Japan (approval number: 2016-235). The findings will be disseminated through peer-reviewed publications and conference presentations and will be reflected on to the national healthcare policy. TRIAL REGISTRATION NUMBER: UMIN000025491.

Indexed as

Lung NeoplasmsPalliative CareEarly Detection of CancerHumansJapanMulticenter Studies as TopicNurse's RoleQuality of LifeRandomized Controlled Trials as Topiconcologypalliative carerespiratory tract tumours

Identifiers

PMID33243791
PMCPMC7692832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.